Table 6 Cox Proportional Hazards Model of Event free survival for patients with local disease
From: Breast cancer in moroccan young women: a retrospective study
| Â | Univariate analysis | Â | Multivariate analysis | Â | ||
|---|---|---|---|---|---|---|
| Â | Hazard ratio | 95% CI | P-value | Hazard ratio | 95% CI | P-value |
Family history | Â | Â | Â | Â | Â | Â |
No | 1.00 | Â | Â | 1.00 | Â | Â |
Yes | 1.25 | 0.66 - 2.34 | 0.49 | 0.86 | 0.41-1.84 | 0.71 |
SBR grading | ||||||
SBR I | 1.00 | Â | Â | 1.00 | Â | Â |
SBR II | 0.66 | 0.26 - 1.64 | 0.36 | 0.62 | 0.17-2.25 | 0.47 |
SBR III | 0.79 | 0.32 - 1.99 | 0.63 | 0.69 | 1.19-2.47 | 0.57 |
Tumor size | ||||||
T1 | 1.00 | Â | Â | 1.00 | Â | Â |
T2 | 1.26 | 0.69 - 2.30 | 0.45 | 1.27 | 0.51-3.17 | 0.61 |
T3 | 1.68 | 0.87 - 3.23 | 0.12 | 1.10 | 0.35-3.14 | 0.93 |
T4 | 1.56 | 0.82 - 2.98 | 0.17 | 1.40 | 0.48-3.81 | 0.57 |
N statut | ||||||
N- | 1.00 | Â | Â | 1.00 | Â | Â |
N+ | 0.79 | 0.55 - 1.13 | 0.20 | 0.74 | 0.42-1.30 | 0.29 |
Stage | ||||||
I | 1.00 | Â | Â | 1.00 | Â | Â |
II | 4.33 | 1.04 - 17.9 | 0.04 | 2.03 | 0.57 - 7.25 | 0.27 |
III | 10.96 | 2.70 - 44.5 | 0.01 | 5.35 | 1.60-17.84 | 0.01 |
ER | ||||||
ER positive | 1.00 | Â | Â | 1.00 | Â | Â |
ER negative | 1.83 | 1.26 - 2.64 | 0.01 | 1.63 | 1.00 - 2.67 | 0.05 |
Adjuvant chemotherapy | ||||||
No | 1.00 | Â | Â | 1.00 | Â | Â |
Yes | 0.45 | 0.28 - 0.73 | 0.001 | 0.90 | 0.33 -2.52 | 0.85 |
Adjuvant hormonotherapy | ||||||
No | 1.00 | Â | Â | 1.00 | Â | Â |
Yes | 0.43 | 0.30 - 0.60 | 0.001 | 0.73 | 0.43 -1.23 | 0.24 |
Surgery type | ||||||
Radical mastectomy | 1.00 | Â | Â | 1.00 | Â | Â |
Conserving surgery | 0.63 | 0.40 - 1.01 | 0.05 | 0.74 | 0.42 -1.13 | 0.30 |
Adjuvant radiotherapy | ||||||
No | 1.00 | Â | Â | 1.00 | Â | Â |
Yes | 0.45 | 0.30 - 0.68 | 0.001 | 0.82 | 0.35-1.19 | 0.64 |